Adverse effects of pindolol augmentation in patients with bipolar depression [6]

Journal of Clinical Psychopharmacology

Volumn 19, Issue 4, 1999, Pages 383-384

  Yatram, L N ^a   Lint, D ^a   Lam, R W ^a   Zis, A P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUVOXAMINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; PINDOLOL; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM; VENLAFAXINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; HYPOMANIA; LETTER; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PSYCHOSIS;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; PINDOLOL;

EID: 0032798290     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199908000-00021     Document Type: Letter

References (8)